dimensional cultured human skin model, and ceramide NS, NP, AS, and AP were extracted from it. The various extracted ceramides were separated by high-performance thin-layer chromatography and quantified by a densitometer. The amount of ceramide AS only in the cultured skin model was significantly higher with the application of GlcCer-based liposomes than that of the nonapplication group, and was also dose dependent. Thus, GlcCer-based liposomes are useful for enriching the ceramide AS levels in a three-dimensional cultured skin model.
stituents of intercellular lipids, play the most important roles in the barrier function of the SC [8, 9] . The characteristic structure of ceramide is a free fatty acid and sphingosine or sphingolipid. The major ceramide of human SC has been classified into more than 9 species by recent analysis techniques [10] . Disruption or a lack of SC lipids decreases skin barrier function and skin moisturization, causing dry skin and sometimes several skin diseases. It was also reported that sphingolipids significantly decreased and inhibited the barrier function of the skin, especially in atopic dermatitis patients [11, 12] . Therefore, the ceramide content in the skin may be increased if glucosylceramide (GlcCer) is successfully delivered to a viable epidermis. However, ceramide is difficult to formulate in topical formulations and cosmetics since it is not soluble or stable in aqueous formulations, which are frequently used for cosmetics.
Serine palmitoyl-CoA transferase is the key enzyme in skin sphingolipid biosynthesis. It is generated through two biosynthesis pathways, GlcCer hydrolysis through glucocerebrosidase [13, 14] and sphingomyelin hydrolysis through sphingomyelinase [15] . Therefore, if GlcCer is hydrolyzed by β-glucocerebrosidase, the ceramide content in the skin will increase.
We reported that application of sphingomyelin-based liposomes to a three-dimensional cultured human skin model increased its type II ceramide (ceramide NS) content [16] . In particular, the small size of sphingomyelinbased liposomes is most effective at increasing ceramide levels [17] .
In this article, GlcCer-based liposomes were prepared and characterized. These GlcCer-based liposomes were applied to a three-dimensional cultured human skin model.
Materials and Methods

Materials
GlcCer from rice bran was kindly provided by Okayasu Shoten Co. Ltd. (Saitama, Japan). Dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) were provided by Nippon Fine Chemical Co. Ltd. (Hyogo, Japan). Hydroxy and nonhydroxy ceramide standards were purchased from Matreya, LLC (Pleasant Gap, Pa., USA). Ceramide AS and AP were obtained from Evonik Goldschmidt GmbH (Essen, Germany). Conduritol B epoxide (CBE) was perchased from Santa Cruz Biotechnology Inc. (Delaware, Calif., USA). LabCyte EPI-MODEL (a three-dimensional cultured human skin model, 0.86 cm 2 /well), medium and enhanced keratinization medium were obtained from Japan Tissue Engineering Co., Ltd. (Gamagori, Aichi, Japan). Phosphate-buffered saline (PBS) powder was obtained from Sigma (St. Louis, Mo., USA). Silica gel 60 (Merck, Darmstadt, Germany) was used for the high-performance thin-layer chromatography (HPTLC) plate. All other reagents were obtained commercially and used without further purification.
Preparation of GlcCer-Based Liposomes
For the assay of this experiment, liposomes composed of GlcCer and DMPC = 4/4 or GlcCer, DMPC and DMPG = 4/4/1 (as a molar ratio) and 0, 5, 10 and 20 mg/ml of final concentration of GlcCer were used and control liposome was prepared without GlcCer. At first, these components were dissolved in chloroform/ methanol. The solvent was evaporated and dried using a rotary evaporator under 40 ° C and 50 hPa before being stored in a vacuum for at least 1 h. The resulting thin lipid film was hydrated with PBS (pH 7.4). Liposomes were then subjected to freezing and thawing for 5 cycles with liquid nitrogen and extruded 5 times through polycarbonate double-membrane filters using an extruder (pore size: 100 nm; Nucleopore, Costar, Cambridge, Mass., USA). Finally, the GlcCer-based liposome suspension was separated by ultracentrifugation at 250,000 g for 15 min (Himac CS100 GXL, Hitachi, Tokyo, Japan). The resultant liposomal pellets were resuspended in PBS (pH 7.4).
Characterization of Liposomes
The size distribution of GlcCer-based liposomes was measured by dynamic light scattering using a Zetasizer (3000HSA, Sysmex, Kobe, Japan). The structure of these liposomes was analyzed by a negative stain with transmission electron microscopy (JEM 1010, Jeol, Tokyo, Japan).
Measurement of Glucocerebrosidase in a Three-Dimensional Cultured Human Skin Model
Twelve wells of the LabCyte EPI-MODEL were minced with scissors on ice. Skin samples were homogenized using a Teflon homogenizer (1,000 rpm, 3 strokes) in 0.25 M sucrose solution. The homogenate was centrifuged under conditions of 600 g for 10 min and the supernatant was considered a skin sample. Separately, 2.5 μ M of C12-NBD-GlcCer was added to 20 μl of 0.6% sodium taurocholate and 0.25% Triton X-100 in 50 m M phosphate citrate buffer (pH 5.0). Diluted C12-NBD-GlcCer solution (20 μl) was added to 180 μl of the homogenized solution (0.05%) of cultured human skin samples or hairless mice skins. The sample (0.2 ml) was incubated at 37 ° C for 15, 30, 45, and 60 min. The reaction was stopped by adding 200 μl chloroform:methanol (2: 1 v/v). The produced C12-NBD-Cer was measured by high-performance liquid chromatography [18] .
Application of GlcCer-Based Liposomes and Extraction of Ceramide from the LabCyte EPI-MODEL
Five, 10, and 20 mg/ml of GlcCer-based liposomes in physiological saline, DMPC/DMPG liposome or saline alone (control) (0.3 ml each) was applied to the SC side of the LabCyte EPI-MOD-EL once per day for 7 days. Cultures of the LabCyte EPI-MODEL were grown at 5% CO 2 and 37 ° C. The medium (1.0 ml) was changed every day. After 7 days, 1.0 ml of the culture medium containing ascorbic acid was then exchanged for enhanced keratinization medium in 24 h, and the ceramide molecules were extracted from the cultured skin model using 6.0 ml of chloroform:methanol The Extraction Method and Lipid Analysis by HPTLC Various ceramides in the LabCyte EPI-MODEL were extracted using the method by Bligh and Dyer [19] . Briefly, the LabCyte EPI-MODEL was dissolved in 6 ml of chloroform:methanol (2: 1 v/v) and sonicated (70 W, 10 min) by a probe type sonicator (Sonifire B-12, Branson Ultrasonics, Conn., USA). The ceramide extracted solution was dried by nitrogen gas, and resolved 0.4 ml of chloroform:methanol (2: 1 v/v). Various ceramide extracts were separated using an HPTLC plate (Silica Gel 60, Merck, Darmstadt, Germany). HPTLC was developed twice with chloroform:methanol:acetic acid = 190: 9:1 (v/v). Ceramide molecules were visualized by treatment with 10% CuSO 4 , 8% H 3 PO 4 aqueous solution, and heating to 180 ° C for 10 min. The amounts of the various types of ceramide (ceramide NS, NP, AS, and AP) on the HPTLC plate were quantitatively determined using a densitometer.
Statistical Analysis
The obtained data were represented as the mean ± SD of 4 experiments. Statistical tests were performed using Dunnett's multiple comparison test (SAS ver. 9.2).
Results
Characterization of GlcCer-Based Liposomes
GlcCer-based liposomes prepared by a hydration method and freeze-thawing method have no entrapped drugs or active ingredients for drug or cosmetic formulations. The particle diameter and zeta potential of sphingomyelin-based liposomes were measured by dynamic laser scattering and electrophoresis, respectively. Liposomes were not prepared only by GlcCer. Therefore, GlcCer/DMPC = 4/4 (molar ratio; total lipid concentration: 26 μmol) and GlcCer/DMPC/DMPG = 4/4/1 (molar ratio; total lipid concentration: 29.25 μmol) were prepared by the thin-layer method. DMPC/DMPG = 4/1 control liposomes (without GlcCer; total lipid concentration: 16.25 μmol) were prepared by the same method. The particle size and zeta potential of the liposomes are summarized in table 1 . The particle diameters of GlcCer/ DMPC = 4/4, GlcCer/DMPC/DMPG = 4/4/1 and DMPC/DMPG = 4/1 were 115, 120 and 137 nm and the zeta potentials were 5, -20 and -36.1 mV, respectively. Figure 1 shows that transmission light scattering was used to measure liposomes by Turbiscan ® MA2000
(Formulaction, Fla., USA). Transmission light scattering of neutrally charged GlcCer liposomes (GlcCer/DMPC) increased in a time-dependent manner. On the other hand, negatively charged GlcCer liposomes (GlcCer/ DMPC/DMPG) were not changed. Due to these results, subsequent examinations used GlcCer/DMPC/DMPG. Figure 2 shows a transmission electron microphotograph of GlcCer/DMPC/DMPG = 4/4/1 ( fig. 2 a) , sug- gesting that GlcCer-based liposomes had a core shell and lamella structure, similar to general liposomes prepared by phosphatidylcholine and cholesterol ( fig. 2 b) . Figure 3 shows glucocerebrosidase activity in the LabCyte EPI-MODEL. Glucocerebrosidase activity was assessed by measuring NBD ceramide. It was measured at 15, 30, 40, and 60 min. The amount of ceramide was 15.0, 28.0, 42.8, and 49.7 μmol/mg protein after application of NBD GlcCer.
Glucocerebrosidase Activity in the LabCyte EPI-MODEL
Changes in Ceramide Amounts in the LabCyte EPI-MODEL after Application of GlcCer Liposomes
Zero (DMPC/DMPG liposomes), 5, 10, and 20 mg/ml of GlcCer liposomes were applied to the SC side for 7 days. The skin model was then cultured in enhanced keratinization medium containing ascorbic acid for 24 h before the ceramides were separated from the cultured skin model and determined by HPTLC. Figure 4 a (ceramide NS), figure 4 b (ceramide NP), figure 4 c (ceramide AS), and figure 4 d (ceramide AP) show the amounts of each ceramide in the cultured skin model. The amounts of ceramide AS were increased by application of GlcCer liposomes in a dose-dependent manner. However, ceramide NS, NP, and AP were not changed by GlcCer liposome application. All ceramides were not changed by DMPC/ DMPG control liposome (without GlcCer) application. Figure 5 shows HPTLC images.
Effect of the Inhibitor for β-Glucocerebrosidase on Ceramide Amount in the LabCyte EPI-MODEL after
Application of GlcCer Liposomes 1 or 3 m M CBE and 10 mg/ml of GlcCer liposomes were cocultured to the SC side for 7 days. The skin model was then cultured in enhanced keratinization medium containing ascorbic acid for 24 h before the ceramides were separated from the cultured skin model and determined by HPTLC. Figure 6 a (ceramide NS), figure 6 b (ceramide NP), figure 6 c (ceramide AS), and figure 6 d (ceramide AP) show the amounts of each ceramide in the cultured skin model. The amounts of ceramide NS, NP, AS and AS were significantly decreased by application of β-glucocerebrosidase inhibitor.
Discussion
Major lipid components in the SC, ceramide species, are generated through GlcCer hydrolysis by glucocerebrosidase in the epidermis [13, 14] . Ceramide is a major component in the SC. It is reported that the SC ceramide content of atopic dermatitis patients is decreased [11, 12] . It is very important to increase ceramide levels in the SC of atopic dermatitis patients effectively to maintain skin barrier function and the water content of the skin. We reported that SC ceramides were increased by applying sphingomyelin liposomes to three-dimensional cultured skin [16, 17] . In this article, GlcCer-based liposomes were prepared and applied on the three-dimensional cultured human skin model.
Liposomes are a vehicle composed of phospholipids for the administration of pharmaceutical drugs and cosmetic formulations [20] [21] [22] . At first, liposomes could not be prepared in GlcCer alone. It was assumed that GlcCer had extremely high lipid solubility. Therefore, liposomes were prepared and added at the same molar ratio of GlcCer and DMPC (GlcCer/DMPC liposomes). As a result, GlcCer/DMPC liposomes could be prepared. Changes in transmission light scattering of these liposomes were observed by Turbiscan MA2000. Transmission light scattering was greatly affected, and it was suggested that the GlcCer/DMPC liposomes were unstable. As the surface charge of the GlcCer/DMPC liposomes we used in this study is neutral, its liposomes aggregated with each other to form secondary particles. Furthermore, DMPG was added to apply a surface charge to the liposomes (GlcCer/ GlcCer/DMPC/DMPG liposomal surfaces have a negative charge, which was electronically repelled and stable. It was decided to perform a future study using stable GlcCer/DMPC/DMPG liposomes. The internal structure of GlcCer-based liposomes was observed using transmission electron microscopy. It was revealed to be a vesicle having a lamellar structure. Its glucocerebrosidase activity was examined in a three-dimensional human cultured epidermis model. NBD-labeled GlcCer was used as a substrate. Results show that GlcCer was produced in a timedependent manner. In addition, a similar result was obtained in mice skin (data not shown). It was revealed that the culture epidermis model had glucocerebrosidase activity. The possibility that ceramide was produced by glu- cocerebrosidase in the epidermis if GlcCer was delivered in the culture epidermis was shown. Ceramide NS, NP, AS, and AP were quantitated after application of 5, 10, and 20 mg/ml of GlcCer liposomes. The amount of ceramide AS increased with application of GlcCer liposomes in a dose-dependent manner. However, ceramide NS, NP, and AP were not changed by GlcCer liposome application. The content of ceramides significantly decreased by applying the inhibitor for β-glucocerebrosidase (CBE). GlcCer, in which ceramide AS connected to glucose, was used in this study. It was suggested that GlcCer applied to the skin epidermis was metabolized by glucocerebrosidase resulting in an increase in ceramide AS.
Generally, it was reported that all ceramides, except acylceramide (ceramide EOS, EOH, EOP), increase from GlcCer in the epidermis. When GlcCer is applied to the skin epidermis, various enzyme expression levels of ceramide in the skin epidermis, except ceramide AS, may increase.
In a future study, it is necessary to confirm changes in the amounts of ceramides, except ceramide AS. Thus, the present sphingomyelin-based liposomes were effective at enriching the ceramide levels in human skin. In addition, liposome formulations are very useful for the application of GlcCer to the skin since the lipid itself is difficult to formulate in conventional formulations. In a future study, it is necessary to investigate changes in the amounts of other ceramides.
Conclusion
GlcCer-based liposomes were applied to the SC of a three-dimensional cultured human skin model, and ceramide AS levels increased. These results suggest that GlcCer-based liposomes have a moisturizing effect and a barrier-maintaining function in the SC.
